$Immune Pharmaceuticals Inc.(IMNP)$ 8-K - Current report Filed: 2018-10-10 AccNo: 0001144204-18-053234 Size: 798 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantItem 3.02: Unregiste 网页链接